Zobrazeno 21 - 30
of 82
pro vyhledávání: ''
Publikováno v:
Bone marrow transplantation. 55(SUPPL 1):108-109
Publikováno v:
Bone marrow transplantation. 55(SUPPL 1):165-166
Publikováno v:
Bone marrow transplantation. 55(SUPPL 1):146-147
Publikováno v:
Bone marrow transplantation. 56(SUPPL 1):207-207
Autor:
Neil Cambronero, K Kowalek, Christopher C. Dvorak, B D Barrows, P C Ursell, Matt S. Zinter, Katrina Kalantar, Joseph L. DeRisi, Peter Oishi
Publikováno v:
Bone Marrow Transplantation
Bone marrow transplantation, vol 52, iss 9
Zinter, MS; Barrows, BD; Ursell, PC; Kowalek, K; Kalantar, K; Cambronero, N; et al.(2017). Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis. BONE MARROW TRANSPLANTATION, 52(9), 1330-1333. doi: 10.1038/bmt.2017.114. UCSF: Retrieved from: http://www.escholarship.org/uc/item/8qq44499
Bone marrow transplantation, vol 52, iss 9
Zinter, MS; Barrows, BD; Ursell, PC; Kowalek, K; Kalantar, K; Cambronero, N; et al.(2017). Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis. BONE MARROW TRANSPLANTATION, 52(9), 1330-1333. doi: 10.1038/bmt.2017.114. UCSF: Retrieved from: http://www.escholarship.org/uc/item/8qq44499
Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis
Publikováno v:
Bone Marrow Transplantation. 52(2):173-182
Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus and all cause mortality. Long-term survivors of hematopoietic cell transplantation (HCT) have a substanti
Autor:
Jan Zuna, Eva Fronkova, Jan Stary, J. Trka, Monika Brüggemann, J. J. M. Van Dongen, Petr Sedlacek, V H J van der Velden, Michaela Kotrova, Renata Formankova
Publikováno v:
Bone Marrow Transplantation, 52(7), 962-968. Nature Publishing Group
Bone Marrow Transplantation, 52(7), 962-968
Bone Marrow Transplantation, 52(7), 962-968
Minimal residual disease (MRD) monitoring via quantitative PCR (qPCR) detection of Ag receptor gene rearrangements has been the most sensitive method for predicting prognosis and making post-transplant treatment decisions for patients with ALL. Despi
Autor:
Straathof, K, Anoop, P, Allwood, Z, Silva, J, Nikolajeva, O, Chiesa, R, Veys, P, Amrolia, P J, Rao, K
Publikováno v:
Bone Marrow Transplantation
Autor:
Simone Cesaro, Chiara Bonini, Carlo Dufour, Peter Dreger, Jakob Passweg, Anna Sureda, D Farge-Bancel, Peter Bader, Arnon Nagler, Francesco Lanza, Kröger N, Andrew R. Gennery, Jürgen Kuball, Mohamad Mohty, Helen Baldomero, R. F. Duarte
Publikováno v:
Bone Marrow Transplantation
Europe PubMed Central
Bone Marrow Transplantation, 51, 786–792. Nature Publishing Group
Europe PubMed Central
Bone Marrow Transplantation, 51, 786–792. Nature Publishing Group
A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers in 47 countries to the 2014 survey. Trends include: continued growth in transp
Autor:
Burns, D M, Rana, S, Martin, E, Nagra, S, Ward, J, Osman, H, Bell, A I, Moss, P, Russell, N H, Craddock, C F, Fox, C P, Chaganti, S
Publikováno v:
Bone Marrow Transplantation
EBV-associated post-transplant lymphoproliferative disease (PTLD) remains an important complication of allogeneic haematopoietic stem cell transplantation (allo-HSCT). We retrospectively analysed the incidence and risk factors for EBV reactivation in